Cannabis is legal-why are cannabis-based pharmaceuticals still controlled?
作者信息
Alkabbani Wajd, Friesen Kevin, Bugden Shawn
机构信息
School of Pharmacy (Alkabbani), Faculty of Science, University of Waterloo, Kitchener, Ontario.
College of Pharmacy (Friesen), Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba.
出版信息
Can Pharm J (Ott). 2020 Oct 7;153(6):323-324. doi: 10.1177/1715163520960500. eCollection 2020 Nov-Dec.
Abstract
摘要
相似文献
1
Cannabis is legal-why are cannabis-based pharmaceuticals still controlled?大麻已合法化，为何以大麻为基础的药品仍受管控？
Can Pharm J (Ott). 2020 Oct 7;153(6):323-324. doi: 10.1177/1715163520960500. eCollection 2020 Nov-Dec.
2
Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.基于大麻的药物——GW制药公司：高CBD、高THC、药用大麻——GW制药公司，THC与CBD比例
Drugs R D. 2003;4(5):306-9. doi: 10.2165/00126839-200304050-00005.
3
[Medical prescription of cannabis-the legal situation becomes clarified].
Schmerz. 2019 Oct;33(5):443-448. doi: 10.1007/s00482-019-00410-7.
4
Out-of-state cannabis purchases in the United States.美国的州外大麻购买。
Drug Alcohol Depend. 2020 Feb 1;207:107822. doi: 10.1016/j.drugalcdep.2019.107822. Epub 2019 Dec 23.
5
Why it is probably too soon to assess the public health effects of legalisation of recreational cannabis use in the USA.为何现在评估美国娱乐用大麻合法化对公共健康的影响可能为时过早。
Lancet Psychiatry. 2016 Sep;3(9):900-6. doi: 10.1016/S2215-0366(16)30071-2. Epub 2016 Jun 28.
6
What is medicinal cannabis?什么是药用大麻？
N Z Med J. 2019 May 3;132(1494):49-56.
7
Availability of legalized cannabis reduces demand for illegal cannabis among Canadian cannabis users: evidence from a behavioural economic substitution paradigm.大麻合法化供应减少了加拿大大麻使用者对非法大麻的需求：来自行为经济学替代范式的证据。
Can J Public Health. 2019 Apr;110(2):216-221. doi: 10.17269/s41997-018-0160-4. Epub 2018 Dec 6.
8
Price elasticity of illegal versus legal cannabis: a behavioral economic substitutability analysis.非法与合法大麻的价格弹性：行为经济学替代分析。
Addiction. 2019 Jan;114(1):112-118. doi: 10.1111/add.14437. Epub 2018 Oct 10.
9
Le marché légal du cannabis suite à sa légalisation au Canada : pistes de réflexion pour un encadrement efficace.加拿大合法化大麻后的合法市场：有效监管的思考方向。
Can J Public Health. 2018 Apr;109(2):215-218. doi: 10.17269/s41997-018-0084-z. Epub 2018 May 9.
10
Cannabis and its derivatives: review of medical use.大麻及其衍生物：医疗用途综述。
J Am Board Fam Med. 2011 Jul-Aug;24(4):452-62. doi: 10.3122/jabfm.2011.04.100280.
本文引用的文献
1
Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.加拿大曼尼托巴省规定的大麻素药物使用持续性：一项基于人群的队列研究。
Addiction. 2019 Oct;114(10):1791-1799. doi: 10.1111/add.14719. Epub 2019 Jul 19.
2
Chronic use of tramadol after acute pain episode: cohort study.急性疼痛发作后曲马多的长期使用：队列研究。
BMJ. 2019 May 14;365:l1849. doi: 10.1136/bmj.l1849.
3
Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study.2004/05至2014/15年曼尼托巴省药用大麻素的使用情况：一项基于人群的横断面研究。
CMAJ Open. 2018 Dec 18;6(4):E637-E642. doi: 10.9778/cmajo.20180109. Print 2018 Oct-Dec.
4
A critique of cannabis legalization proposals in Canada.对加拿大大麻合法化提案的批判。
Int J Drug Policy. 2016 Aug;34:5-10. doi: 10.1016/j.drugpo.2016.05.002. Epub 2016 May 13.
5
The abuse potential of the synthetic cannabinoid nabilone.合成大麻素纳布啡的滥用潜力。
Addiction. 2010 Mar;105(3):494-503. doi: 10.1111/j.1360-0443.2009.02776.x.
Zotero 插件